Cipla500087Pharmaceuticals
Cipla's Q2 results showed margin beat but net profit miss, with stock reacting negatively amid concerns on US revenue guidance
By ScoutQuest · · 1 min read
- Net profit change
- 35 percent down
- Revenue change
- 2.4 percent down
- EBITDA change
- 27 percent down
- Margins this quarter
- 18.7 percent
- Margins last year
- 25 percent
Heard on business television between 13:32:14 - 13:35:14 IST.
- Net profit was down 35%, revenue down 2.4%, EBITDA down 27%, with margins at 18.7% versus 25% last year.
- Revenue was in line with estimates but net profit missed due to lower other income year-on-year.
- Analyst Thomas O'Brian of Share Khan said margin improvement was a positive, with management guiding towards closer to 20% margins for the full year, expecting H2 to be better.
- Key drug impact (Lanreotide and Revlimid) cited as reasons for the topline miss; company will need new drug launches to boost revenue going forward.
- O'Brian said the $1 billion North America revenue guidance will likely be difficult to meet in H2 and expects a revised guidance to be given in the concall; stock reaction linked to concerns over US sales miss of around 200 crore rupees versus consensus.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Cipla
Cipla reported modest Q2 numbers but maintained its US revenue and EBITDA margin guidance, prompting mixed brokerage reactions
28 Oct 2026
Cipla posts audio recording of Q2/H1 FY27 earnings conference call on its website
27 Oct 2026
Cipla's Q2 results were largely in line with estimates, with a dip in profit and muted US sales due to supply issues
27 Oct 2026
Source: Live TV News Channel · 27 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.